The Procter & Gamble Company

The two forensic figures on file give a mixed but mostly reassuring picture. The operating cash flow to net income ratio for fiscal 2025 is 1.12, meaning operating cash flow ran about 12% above net income ($17.82 billion versus $15.97 billion). In plain terms, reported profit is backed by cash generated during the year, which is the relationship a careful reader typically looks for. Revenue growth for fiscal 2025 was 0.3%, with sales of $84.28 billion versus $84.04 billion, so sales were nearly flat while net income grew about 7%. The filing does not break out how much of that gap comes from one-time items, so readers may want to look at the non-core charges discussed in the restructuring and Glad sections. The Beneish M-Score, Altman Z-Score, Piotroski F-Score and Fog Index are not on file for this company, so this synthesis gives no values for them. The six-month 10-Q shows adjusted free cash flow of $8.7 billion, equal to 95% of net earnings, which supports the cash conversion picture. The Focused Portfolio plan includes a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027, but the filing does not quantify the resulting savings. The Glad exit is expected to produce an after-tax gain of $250 to $300 million in the third quarter of fiscal 2026, which is a one-time item separate from core sales. Geographic exposure is significant: the largest international markets were about 21% of fiscal 2025 net sales, and the Russia business was 1% of consolidated net sales, net earnings and net assets.

Catalyst.Management's recent narrative centers on modest top-line growth and a restructuring program. In the six months ended December 31, 2025, net sales were $44.6 billion, up $975 million or 2%, with organic sales up 1%. Beauty, Grooming and Health Care grew mid-single digits, while Baby, Feminine & Family Care declined low single digits. Diluted EPS rose 7% to $3.73, while Core EPS, which excludes incremental restructuring charges, rose 2% to $3.87. The June 2025 Focused Portfolio, Supply Chain and Productivity Plan targets $1.5 to $2.0 billion in before-tax restructuring costs over two years. A planned exit from the Glad joint venture is expected to bring approximately $500 million in cash.

Hidden risk.A casual reader may focus on earnings growth and miss the cash and debt picture. Fiscal 2025 operating cash flow was $17.82 billion, down from $19.85 billion in fiscal 2024, a decline of about 10%, even though net income rose about 7% to $15.97 billion. Total debt, meaning current debt plus long-term debt, rose from $34.5 billion at June 30, 2025 to $36.6 billion at December 31, 2025. Over the same period the company continued treasury stock purchases and dividends. Readers may want to look at how these shareholder payments compare with cash generated from operations in future periods.